Learn how gefapixant, a first-in-class P2X3 receptor antagonist, targets cough hypersensitivity to reduce chronic refractory cough, improve quality of life, and offer an alternative to off‑label neuromodulators.
Learn what retatrutide is, how this next‑generation triple agonist (GLP‑1, GIP, and glucagon) works for weight loss, obesity, and metabolic health, and see key phase 2 clinical trial results on body‑weight reduction and cardiometabolic benefits.
Learn what ensifentrine is, how its dual PDE3/4 inhibition works, and why it’s an emerging inhaled treatment option for COPD. Review its bronchodilatory and anti-inflammatory effects, phase 2b and phase 3 clinical trial results, and impact on lung function, symptoms, and exacerbations.
Discover how zuranolone (SAGE-217), a first-in-class oral neuroactive steroid, offers rapid relief for major depressive disorder and postpartum depression through short 14-day treatment cycles and a novel GABAA receptor mechanism, reshaping options for treatment-resistant depression.
Discover how AI-driven pharmacovigilance is transforming drug safety with intelligent systems that automate case processing, enhance signal detection, and enable proactive risk management across real-world data sources.
Learn what marituglutide is, how its dual GLP-1/GIP “twincretin” mechanism works, and how it may outperform semaglutide for weight loss, glycemic control, and metabolic health in obesity and type 2 diabetes.
Discover how AI and machine learning are revolutionizing pharmacovigilance by enabling real-time signal detection, mining unstructured data from EHRs and social media, and improving drug safety monitoring across the product life cycle.
Discover how tirzepatide, a once-weekly dual GIP/GLP‑1 “twincretin,” is transforming type 2 diabetes and obesity treatment through engineered peptide design, extended half‑life, and superior HbA1c and weight reduction compared with traditional GLP‑1 agonists.
Learn what zuranolone is, how this first-in-class oral neuroactive steroid works on GABA-A receptors, and why it’s generating buzz as a rapid-acting treatment option for major depressive disorder (MDD) and postpartum depression (PPD).
Discover how AI-powered intelligent signal detection is reshaping pharmacovigilance. Learn how NLP and machine learning enhance drug safety, improve signal prioritization, and help meet regulatory expectations in modern pharmacovigilance.